Biohaven Pharmaceutical Holding Company Ltd.

NYSE:BHVN

39.31 (USD) • At close February 4, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Omzet 0000000-215.0790215.079318.852190.013135.7492.93343.82335.11417.6649.6981.15100000000000
Kosten van de omzet 00.9770.9410.9480.8570.80.76435.7410.3770.45626.34235.94925.51417.33912.8629.9684.2443.0580.42400000000000
Brutowinst 0-0.977-0.941-0.948-0.857-0.8-0.764-250.82-0.377214.623292.51154.064110.22675.59430.96125.14613.426.640.72700000000000
Brutowinstmarge 00000001.16600.9980.9170.8110.8120.8130.7070.7160.760.6850.63200000000000
Onderzoek- en ontwikkelingskosten 157.607314.819155.972134.81395.51779.4963.461137.04452.845177.08770.09641.81846.97377.428107.11173.45957.04442.42556.0766.01961.674175.97741.00347.36229.05275.57966.75534.99621.01910.74
Algemene en administratieve kosten 20.56118.95327.26818.89815.0314.52114.32176.36814.79220.02319.6779.0658.5199.9159.915000068.9728.78223.23513.4627.5749.0647.85712.5274.5714.1993.757
Verkoop- en marketingkosten 00-0.941-0.948000000000160.142149.608000000000000000
Verkoop-, algemene en administratieve kosten 20.56118.95326.32717.9515.0314.52114.32176.36814.79220.02319.6779.0658.519170.057159.523122.387119.533124.80295.60168.9728.78223.23513.4627.5749.0647.85712.5274.5714.1993.757
Overige kosten 004.3057.7434.6865.8428.229-1.8380-0.067-0.0041.454-0.00500000000000000000
Bedrijfskosten 178.168333.772182.299152.763110.54794.01177.782213.41267.637197.1189.77350.88355.492247.485266.634195.846176.577167.227151.671134.98990.456199.21254.46554.93638.11683.43679.28239.56725.21814.497
Bedrijfsresultaat -178.168-333.772-183.24-153.711-110.547-94.011-77.782-213.412-67.637-197.11-89.773-50.883-55.492-171.891-235.673-170.7-163.157-160.587-150.944-134.989-90.456-199.212-54.465-54.936-38.116-83.43679.282-39.567-25.218-14.497
Bedrijfsresultaat ratio 00000000.9920-0.916-0.282-0.268-0.409-1.85-5.378-4.861-9.237-16.559-131.14200000000000
Totaal overige inkomsten en kosten netto 17.80514.1784.3057.7434.6865.8428.229-1.8380-0.067-0.0041.454-0.005-34.918-25.831-42.53-29.482-19.689-21.299-14.346-15.388-11.8-7.73-6.344-1.128-1.93920.179-3.293-12.823-4.063
Inkomen voor belasting -160.363-319.594-178.935-145.968-105.861-88.169-69.553-215.25-67.637-197.177-89.777-49.429-55.497-206.809-261.504-213.23-192.639-180.276-172.243-149.335-105.844-211.012-62.195-61.28-39.244-85.37599.461-42.86-38.041-18.56
Inkomen voor belasting ratio 00000001.0010-0.917-0.282-0.26-0.409-2.225-5.967-6.073-10.906-18.589-149.64600000000000
Belastingkosten -0.0590.1770.569-1.212-3.2872.1770.939-14.1431.2166.117.2552.457-1.1324.353.8244.8863.9890.6580.694-0.0710.3230.0580.1090.1610.0250.087-0.6470.0550.3990.193
Nettowinst -160.304-319.771-179.504-144.756-102.574-90.346-70.492-201.107-68.853-203.287-97.032-51.886-54.365-210.619-264.968-217.736-195.189-180.934-172.937-149.264-106.167-211.07-62.304-61.441-39.269-85.462100.108-42.915-38.44-18.753
Nettowinstmarge 00000000.9350-0.945-0.304-0.273-0.401-2.266-6.046-6.201-11.05-18.657-150.24900000000000
WPA (Winst Per Aandeel) -1.7-3.64-2.2-1.81-1.5-1.32-1.03-3.3-1.75-5.67-2.71-1.45-1.52-3.23-4.27-4.49-3.27-3.08-3.07-0.003-2.04-4.67-1.41-1.53-1.01-2.322.753-1.19-1.48-1.43
Verwaterde WPA -1.7-3.64-2.2-1.81-1.5-1.32-1.03-3.3-1.75-5.67-2.71-1.45-1.52-3.23-4.27-4.49-3.27-3.08-3.07-0.003-2.04-4.67-1.41-1.53-1.01-2.322.753-1.19-1.48-1.43
EBITDA -176.174-331.818-181.794-151.817-109.009-92.18-76.133-214.906-67.26-196.695-89.523-50.198-55.266-56.022-56.022-215.296-163.157-160.587-150.944-134.989-90.456-199.212-54.465-54.936-38.116-83.43679.282-39.567-25.218-14.497
EBITDA ratio 00000000.9910-0.915-0.281-0.264-0.407-1.85-5.378-6.131-9.237-16.559-131.14200000000000